TetraLogic Pharmaceuticals Corporation (TLOG)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026
0.00%
Market Cap 24.00
Revenue (ttm) n/a
Net Income (ttm) -40.72M
Shares Out 24.32M
EPS (ttm) -1.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 17,051
Open 0.0000
Previous Close 0.0001
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0010
Beta 29.62
RSI 46.13
Earnings Date n/a

About TLOG

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cuta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 30
Stock Exchange OTCMKTS
Ticker Symbol TLOG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.